Member Info for doggo

You turd muppets who doubted me...

Let’s see...

Actually, they aren’t now a hypothetical, I know a company that’s developing them now and will be in widespread use very soon...

Admit it you’ve never heard the term have you?

Calorie restriction mimetics, also known as energy restriction mimetics, are a hypothetical class of dietary supplements or drug candidates that would, in principle, mimic the substantial anti-aging effects that calorie restriction has on many laboratory animals and humans.

Note the word hypothetical in the above paragraph. If someone actually created these, there would a decent chance of a good return for anyone invested...agree?

Got it at 330pm today but saw the sellers so thought I’d just hold it back..

Will be on tomorrow

I beat them to it

As you may or may not know Portage BOD and major shareholders are Intensity Therapeutics BOD and major shareholders

Here’s an interesting snippet...

Business plan
Portage is in the business of licensing, researching and developing potential drug candidates. The Company would like to assemble a portfolio of products: diversified as to their stage of development and pathology. Then inexpensively take them through to phase 2b clinical trial often called proof of concept (“POC”).
Upon a successful POC we will monetize the products through sale or license to big Pharma.
We are seeking discovery and co-development partners in areas such as cancer, infectious disease, neurology and psychiatry developing novel targeted therapies, stem cell therapy and even older marketed products that have been found to have novel patentable characteristics that bring new value to patients.
The goal is to grow Portage by carefully selecting compelling products to license, acquire or position as a joint venture. The product portfolio will be carefully selected to be at various stages in drug development but with an overriding characteristic of being attractive to large pharmaceutical companies. Portage has a strong team with extensive experience in drug development that will be leveraged to source the aforementioned products, to undertake the due diligence and guide them through drug development to monetization.

True..

There’s a lot of people aware of FFWD who aren’t holding. Each and everyone thinking they can jump the market when the SP moving news lands.

That’s impossible.. Quint proved that Friday, he sensed news could land and tried to buy £30k at lunchtime. He couldn’t do it. Other people had difficulty buying anything at close Friday.

When JUV lists this year, I’ll wager our chunk will be worth more than FFWD current NAV on list day.

Obviously sellers today don’t read any RNS ever and just follow the last 4 trades. A few traders have taken a quick profit no worries they won’t be around for the rerate(s) to come.

I’m not going to mention Factom in this particular message just VEMO & JUV.
Vemo are due to close their PREMIUM raise...this will have a substantial & dramatic effect on NAV. We know this is now due. Juv series B part ii is going to raise a further $53 - 75 million. That’s 1p on the NAV that is 12p currently. We trade historically at 30% premium. The PF is now reaching a mid term maturity that wasn’t there a couple of years ago.

The 3 in the PF that will ultimately give the largest potential gains in order

Kick off with VEMO JUV Intensity

Don’t know how many times we need to explain that Factom.inc is the company that Bill Gates works with, Department of Homeland Security works with, that has all the contracts see Matadors message a few down from here. The Factom coin value has NOTHING to do with FFWD. It could be valued at 10cents or $100,000 no issues here.

Think of Factom.inc as Sainsbury’s FCT is a nectar token connected to points make prizes or whatever you lot convert your nectar points into. Which do you want to hold? Sainsbury’s stock or a nectar card?

Series B part ii will close very soon raising another $50 million. There’s one company within their portfolio that they have a controlling interest in that is going to enable a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs.Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD) BY THE END OF THIS YEAR.

Once they can create a liver, they will move onto creating a thymus, kidneys and pancreas. I am sure we have all known someone who this could have saved.

This is one of 18 companies that they will have within their (and by default our) PF before the end of 2019. They will IPO & list during 2019 with an initial valuation over £1 billion.

We aren’t just a company that holds a % of Factom. Factom is a monster but doesn’t quite make my top 3.

We are a tranquil happy house nowadays Robbo

Was always going to bounce hard...news stacked and trading at a huge 3p below NAV when we always trade at 30% above NAV

The Factom Protocol is designed so that any data can be entered into the blockchain. The nodes (servers) operating the network do nothing with the data that is entered, the nodes just store the data. This is the definition of a “pure data blockchain”
Errors in the instructions cannot occur with Factom because the network is not using the data as instructions. The Factom® Protocol proves a piece of information existed at a certain time and was entered by a specific organisation/person. This simple storage of pure data is very powerful and can be used by developers to create applications on top of the Factom Protocol built in the programming language of their choice.

Useful digital identity will be public chain based. Even for DHS. Factom's authority nodes are run by companies, not random guys in basements. Every real world blockchain application in the future will have private and public components in my view. That's called scaling world wide. Other chains don't know how to do this without losing the ledger, which is what makes Factom compelling.

Factom is out of the box a hybrid public / private blockchain tech. This, when we gain traction, as we are, will be massive.

Very very big..

Their clients include: NASA, Department of Homeland Security, US Airforce, US Navy, US Coast Guard, US Marine Corps, OSD and defense agencies (Department of Defense), US Joint Services and Agencies

SPA’s intimate knowledge of its US Department of Defence and federal customer’s challenges coupled with Factom’s blockchain technology solutions offers a significant opportunity to help transition blockchain from a buzzword into actionable solutions that improve efficiency and security for key federal organizations."